by LB | Sep 29, 2025 | myopia control, Uncategorized
09/25/2025 “FDA authorized marketing of the Essilor Stellest eyeglass lenses to correct myopia, commonly referred to as nearsightedness, with or without astigmatism and to slow the progression of the disease in children 6 to 12 years old at the initiation of...
by LB | Oct 30, 2021 | near vision eye drops, Uncategorized
FDA approves Allergan’s Vuity – first eye drop to treat presbyopia. https://www.ophthalmologytimes.com/view/fda-approves-eye-drops-for-treatment-of-presbyopia The prescription eye drop is reported to improve near and midrange vision. Vuity takes effect in...
by LB | Mar 2, 2021 | near vision eye drops, Uncategorized
eyedrops for presbyopia: phase 3 trials https://eyewire.news/articles/allergan-announces-positive-phase-3-topline-results-for-investigational-eye-drop-for-the-treatment-of-presbyopia: “AGN-190584 is an investigational optimized formulation of pilocarpine, a...
by LB | Oct 7, 2017 | Office Updates, Uncategorized
Fundraiser Workshop for Bay Area Cancer Connections Oct 21 5:15Pm Vision exercises can reduce overall eye strain and improve sports performance. During this workshop you will use various optometric instruments to improve focusing and eye muscle coordination. Contact...
